Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LNAnteLTS:0OR2 -0.88%76 EV-to-OCF is 11.76 as of Aug. 15, 2026, which is 7% above its 10-year median of 11.01. GuruFocus rates LTS:0OR2 with a GF Score™ of 76/100 and a GF Value™ of €29.81 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 682 Healthcare Providers & Services companies, LNAnte ranks worse than 60.7% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, LNAnte's Enterprise Value is €1,168.7 Mil.
LNAnte's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €99.4 Mil. Therefore, LNAnte's EV-to-OCF for today is 11.76.
The historical rank and industry rank for LNAnte's EV-to-OCF or its related term are showing as below:
LTS:0OR2'
s EV-to-OCF Range Over the Past 10 Years
Min: 8.73 Med: 11.01 Max: 28.11
Current: 11.94
During the past 13 years, the highest EV-to-OCF of LNAnte was 28.11. The lowest was 8.73. And the median was 11.01.
LTS:0OR2's EV-to-OCF is ranked worse than 60.7% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.91
vs LTS:0OR2: 11.94
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-08-15), LNAnte's stock price is €33.90.
LNAnte's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.354. Therefore, LNAnte's PE Ratio (TTM) for today is 14.40.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
LNAnte's share price for today is €33.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LNAnte's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.354.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
LNAnte EV-to-OCF Related Terms
LNAnte EV-to-OCF Historical Data
* Premium members only.
The historical data trend for LNAnte's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LNAnte's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LNAnte EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LNAnte's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where LNAnte's EV-to-OCF falls into.
LNAnte's current Enterprise Value is €1,168.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LNAnte's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €99.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LNAnte (LTS:0OR2) has a EV-to-OCF of 11.76 as of Aug. 15, 2026. This is near median its historical median of 11.01. Over the past decade, LNAnte's EV-to-OCF has ranged from 8.73 to 28.11. According to the industry distribution chart, LNAnte ranks #414 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 60.7%.
Is LNAnte's EV-to-OCF too high?
LNAnte's current EV-to-OCF of 11.76 is near median its 10-year median of 11.01. Over the past 10 years, this metric has ranged from a low of 8.73 to a high of 28.11. The Healthcare Providers & Services industry median EV-to-OCF is 8.91. LNAnte's value of 11.76 is 32% above this industry median. Based on the distribution chart, LNAnte ranks #414 out of 682 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LNAnte has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LNAnte's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, LNAnte ranks #414 out of 682 companies for EV-to-OCF. This places LNAnte in the lower half of its industry. The industry median EV-to-OCF is 8.91. LNAnte's value of 11.76 is 32% above this benchmark. Historically, LNAnte's own EV-to-OCF has ranged from 8.73 to 28.11 over the past decade. While the company's 10-year median is 11.01 vs. the industry median of 8.91, LNAnte has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.91, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LNAnte's current EV-to-OCF of 11.76 is 32% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LNAnte's current EV-to-OCF is 11.76, which is near median its own 10-year median of 11.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LNAnte stock overvalued right now?
Based on GuruFocus' analysis, LNAnte (LTS:0OR2) is currently considered Modestly Overvalued. The stock's GF Value™ is €29.81, compared to a current price of €33.90 — trading 13.7% above its estimated fair value. The current EV-to-OCF is 11.76, which is near median its 10-year median of 11.01 and 32% above the Healthcare Providers & Services industry median of 8.91. LNAnte's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For LNAnte (LTS:0OR2), the current EV-to-OCF is 11.76 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LNAnte (LTS:0OR2) Overvalued in 2026?
Based on GuruFocus' analysis, LNAnte stock appears to be overvalued.
The current stock price of €33.90 is trading 13.7% above its estimated GF Value™ of €29.81.
GuruFocus considers LNAnte to be Modestly Overvalued.
Key valuation signals for LTS:0OR2:
EV-to-OCF: 11.76 (near median its 10-year median of 11.01)
GF Value™: €29.81 vs. price of €33.90 (13.7% above fair value)
Industry Position: 32% above the Healthcare Providers & Services median (#414 of 682)
No single metric tells the full story. See the LTS:0OR2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LNA Sante SA is engaged in the management and operation of retirement homes, nursing homes, follow-up care clinics, rehabilitation centers, centers for the disabled and handicapped ageing.
76GF Score
Get the complete analysis for LTS:0OR2
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0OR2 has been successfully added to your 
